Gene therapy approaches to ventricular tachyarrhythmias.

about

Cardiac gene therapy: from concept to reality.Ventricular fibrillation: triggers, mechanisms and therapies.Distinguishing epicardial fat from scar: analysis of electrograms using high-density electroanatomic mapping in a novel porcine infarct model.

P2860

Q37965045-90805CBC-6E0B-47DA-A990-15F940BCB252 Q38819031-45156029-A777-40D1-886F-E43074DA1941 Q42014118-CFFA2B93-7A68-4B4E-9BD5-065A21EB528A

P2860

Gene therapy approaches to ventricular tachyarrhythmias.

Item

http://www.wikidata.org/entity/Q36238863

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Gene therapy approaches to ventricular tachyarrhythmias.

@ast

Gene therapy approaches to ventricular tachyarrhythmias.

@en

type

Item

label

Gene therapy approaches to ventricular tachyarrhythmias.

@ast

Gene therapy approaches to ventricular tachyarrhythmias.

@en

prefLabel

Gene therapy approaches to ventricular tachyarrhythmias.

@ast

Gene therapy approaches to ventricular tachyarrhythmias.

@en

P1476

Gene therapy approaches to ventricular tachyarrhythmias.

@en

P2093

J Kevin Donahue

http://www.w3.org/2001/XMLSchema#string

Kamilla Kelemen

http://www.w3.org/2001/XMLSchema#string

Tetsuo Sasano

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature

Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium.

Biological pacemaker created by gene transfer.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

Catheter ablation of ventricular tachycardia in patients with coronary heart disease. Part II: Clinical aspects, limitations, and recent developments.

Molecular ablation of ventricular tachycardia after myocardial infarction.

Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

P304

S187-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JELECTROCARD.2007.05.036

http://www.w3.org/2001/XMLSchema#string

P433

6 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5854127

http://www.w3.org/2001/XMLSchema#string

P698

17993320

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

2121616

http://www.w3.org/2001/XMLSchema#string

Gene therapy approaches to ventricular tachyarrhythmias.

about

P2860

P2860

Gene therapy approaches to ventricular tachyarrhythmias.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932